JPS58407B2 - インフルエンザウイルスから血球凝集素およびノイラミニダ−ゼ成分の分離方法 - Google Patents

インフルエンザウイルスから血球凝集素およびノイラミニダ−ゼ成分の分離方法

Info

Publication number
JPS58407B2
JPS58407B2 JP50006975A JP697575A JPS58407B2 JP S58407 B2 JPS58407 B2 JP S58407B2 JP 50006975 A JP50006975 A JP 50006975A JP 697575 A JP697575 A JP 697575A JP S58407 B2 JPS58407 B2 JP S58407B2
Authority
JP
Japan
Prior art keywords
virus
components
hemagglutinin
neuraminidase
influenza
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP50006975A
Other languages
English (en)
Japanese (ja)
Other versions
JPS50100224A (enExample
Inventor
ゲルハルト・シユミツト
ヘルムート・バツハマイエル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS50100224A publication Critical patent/JPS50100224A/ja
Publication of JPS58407B2 publication Critical patent/JPS58407B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
JP50006975A 1974-01-14 1975-01-14 インフルエンザウイルスから血球凝集素およびノイラミニダ−ゼ成分の分離方法 Expired JPS58407B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (enExample) 1974-01-14 1974-01-14

Publications (2)

Publication Number Publication Date
JPS50100224A JPS50100224A (enExample) 1975-08-08
JPS58407B2 true JPS58407B2 (ja) 1983-01-06

Family

ID=4187233

Family Applications (2)

Application Number Title Priority Date Filing Date
JP50006975A Expired JPS58407B2 (ja) 1974-01-14 1975-01-14 インフルエンザウイルスから血球凝集素およびノイラミニダ−ゼ成分の分離方法
JP56012831A Expired JPS6035326B2 (ja) 1974-01-14 1981-01-29 インフルエンザワクチンの製造法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP56012831A Expired JPS6035326B2 (ja) 1974-01-14 1981-01-29 インフルエンザワクチンの製造法

Country Status (27)

Country Link
JP (2) JPS58407B2 (enExample)
AT (1) AT345449B (enExample)
AU (1) AU500250B2 (enExample)
BE (1) BE824372A (enExample)
CA (1) CA1049406A (enExample)
CH (1) CH589453A5 (enExample)
CS (1) CS191254B2 (enExample)
DD (1) DD116239A5 (enExample)
DE (1) DE2500785B2 (enExample)
DK (1) DK140003B (enExample)
ES (1) ES433759A1 (enExample)
FI (1) FI54053C (enExample)
FR (1) FR2257305B1 (enExample)
GB (1) GB1498261A (enExample)
HK (1) HK56380A (enExample)
HU (1) HU173920B (enExample)
IE (1) IE40794B1 (enExample)
IL (1) IL46426A (enExample)
MY (1) MY8100204A (enExample)
NL (1) NL166622C (enExample)
NO (1) NO143128C (enExample)
PH (1) PH14458A (enExample)
PL (1) PL93689B1 (enExample)
SE (1) SE427238B (enExample)
SU (1) SU616997A3 (enExample)
YU (1) YU41289B (enExample)
ZA (1) ZA75259B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
ATE494906T1 (de) * 2005-11-01 2011-01-15 Novartis Vaccines & Diagnostic Von zellen stammende virale impfstoffe mit geringen mengen an rest-zell-dna
JP5535910B2 (ja) * 2007-08-28 2014-07-02 バクスター・インターナショナル・インコーポレイテッド ウイルスワクチンを生産する方法
CA2930634C (en) 2013-11-15 2023-05-09 Novartis Ag Removal of influenza nuclear protein (np) from influenza virus preparations

Also Published As

Publication number Publication date
NO750031L (enExample) 1975-08-11
JPS50100224A (enExample) 1975-08-08
ATA21475A (de) 1978-01-15
DK140003C (enExample) 1979-10-29
NL7500301A (nl) 1975-07-16
YU5875A (en) 1984-04-30
CA1049406A (en) 1979-02-27
CS191254B2 (en) 1979-06-29
FI750014A7 (enExample) 1975-07-15
HU173920B (hu) 1979-09-28
DE2500785B2 (de) 1980-01-03
IL46426A0 (en) 1975-04-25
IL46426A (en) 1978-01-31
BE824372A (fr) 1975-07-14
SE427238B (sv) 1983-03-21
NL166622B (nl) 1981-04-15
NO143128B (no) 1980-09-15
FR2257305A1 (enExample) 1975-08-08
SU616997A3 (ru) 1978-07-25
JPS6035326B2 (ja) 1985-08-14
DD116239A5 (enExample) 1975-11-12
AT345449B (de) 1978-09-11
DE2500785C3 (enExample) 1980-09-11
MY8100204A (en) 1981-12-31
CH589453A5 (enExample) 1977-07-15
HK56380A (en) 1980-10-16
IE40794L (en) 1975-07-14
PL93689B1 (enExample) 1977-06-30
NO143128C (no) 1980-12-29
DE2500785A1 (de) 1975-07-31
IE40794B1 (en) 1979-08-15
FI54053B (fi) 1978-06-30
ZA75259B (en) 1976-08-25
FR2257305B1 (enExample) 1982-03-19
DK140003B (da) 1979-06-05
SE7500130L (enExample) 1975-07-15
PH14458A (en) 1981-07-29
JPS56127319A (en) 1981-10-06
NL166622C (nl) 1981-09-15
AU7730575A (en) 1976-07-15
FI54053C (fi) 1978-10-10
AU500250B2 (en) 1979-05-17
DK1475A (enExample) 1975-09-01
YU41289B (en) 1987-02-28
GB1498261A (en) 1978-01-18
ES433759A1 (es) 1977-02-16

Similar Documents

Publication Publication Date Title
US5643577A (en) Oral vaccine comprising antigen surface-associated with red blood cells
Yap et al. The recovery of mice from influenza virus infection: adoptive transfer of immunity with immune T lymphocytes
Johansson et al. Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. II. Sequential infection of mice simulates human experience.
CA1174599A (en) Herpes simplex type i subunit vaccine
US4009258A (en) Influenza vaccine containing a recombinant, antigenically hybridized virus and method of using the same
US4064232A (en) Process for isolating the immunogenic components of influenza viruses
Rytel et al. The Influence of Cortisone on Experimental Viral Infection: VIII. Suppression by Cortisone of Interferon Formation in Mice Injected With Newcastle Disease Virus
US5766601A (en) Cross-reactive influenza a immunization
EP0480949B2 (en) Production of viral vaccine
US4140762A (en) Influenza sub-unit vaccine
US4029763A (en) Influenza vaccine containing purified neuraminidase antigen and method of using the same
JP2025170230A (ja) 多価ネコワクチン
JP2000512263A (ja) インフルエンザワクチン
JPS6035326B2 (ja) インフルエンザワクチンの製造法
Hocart et al. Preparation and characterization of a purified influenza virus neuraminidase vaccine
US3156620A (en) Attenuated live rabies vaccine and method of preparing the same
JP3945842B2 (ja) 弱毒性ニューカッスル病ウイルスワクチン
BR112020008958A2 (pt) vacina contra calicivírus felino
Mifune et al. A mouse model for the pathogenesis and postexposure prophylaxis of rabies
DE2829089A1 (de) Subunit-vakzine
US3769415A (en) Method of preparing a killed vaccine for oral use
Kilbourne Influence of cortisone on experimental viral infection. II. Effects on antibody formation and acquired immunity.
Laver et al. Preparation and immunogenicity of a purified influenza virus haemagglutinin and neuraminidase subunit vaccine
US4540669A (en) Herpes simplex type I subunit vaccine
KR790001144B1 (ko) 인플루엔자 백신의 제조방법